Suzanne Topalian, M.D. (Chair)
Professor, Surgery and Oncology,
Johns Hopkins Medicine
Director, Melanoma Program,
Kimmel Cancer Center
Associate Director, Bloomberg~Kimmel
Inst. for Cancer Immunotherapy
Jeff Allen, Ph.D.
President and CEO, Friends of Cancer Research
James P. Allison, Ph.D.
Professor and Chair of Immunology University of Texas MD Anderson Cancer Center
Boris Bastian, M.D.
Clinical Professor, Department of Dermatology University of California, San Francisco
Gideon Bollag, Ph.D.
Chief Executive Officer, Plexxikon, Inc.
Glenn Dranoff, M.D.
Global Head of Exploratory Immuno-Oncology Novartis Pharmaceuticals Corporation
Levi Garraway, M.D., Ph.D.
Senior Vice President, Global Development & Medical Affairs, Lilly Oncology, Eli Lilly and Company
Allan C. Halpern, M.D.
Chief, Dermatology Service, Memorial Sloan Kettering Cancer Center
Reid Huber, Ph.D.
Executive Vice President,
Chief Scientific Officer
Nageatte Ibrahim, M.D.
Development Lead, Merck Research Laboratories
Jeffrey Legos, Ph.D.
Senior Vice President, Global Program Head, Novartis Pharmaceuticals Corporation
Richard Marais, Ph.D., FMedSci
Director, Cancer Research UK Manchester Institute
Ira Mellman, Ph.D.
Vice President of Research Oncology, Genentech
Fouad Namouni, M.D.
Senior Vice President and Head of Oncology Development, Bristol-Myers Squibb
David Reese, M.D.
Senior Vice President, Translational Science, Amgen, Inc.
Neal Rosen, M.D., Ph.D.
Enid A. Haupt Chair in Medical Oncology, Memorial Sloan Kettering Cancer Center
Steven Rosenberg, M.D.
Chief, Surgery Branch - National Cancer Institute, National Institutes of Health
Michael Weber, Ph.D.
Director, Cancer Center, Weaver Professor of Oncology, University of Virginia
Dr. Jedd Wolchok
*All organizational affiliations and titles are listed for identification purposes only. All individuals serve in their personal capacity only and not as a representative of their employer.